Bijal Shah, MD, Moffitt Cancer Center
Advertisement
Articles by Bijal Shah, MD, Moffitt Cancer Center
Advertisement
Latest Updated Articles
An Introduction to Mantle Cell Lymphoma & KTE-X19Published: June 24th 2020 | Updated:
Future Directions in Mantle Cell LymphomaPublished: June 24th 2020 | Updated:
A Look at ZUMA-2 TrialPublished: June 24th 2020 | Updated:
Bruton Tyrosine Kinase InhibitorsPublished: June 24th 2020 | Updated:
ASCO 2020: ZUMA-2 UpdatePublished: June 24th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5